Is Broadcom Stock a Millionaire Maker?
Broadcom (Nasdaq: AVGO) stock has gone up more than 64%…
Buy
60
IBN Quote, Financials, Valuation and Earnings
Last price:
$33.86
Seasonality move
:
4.75%
Day range:
$34.05 - $34.33
52-week range:
$25.13 - $34.33
Dividend yield:
0.7%
P/E ratio:
20.30x
P/S ratio:
5.04x
P/B ratio:
3.32x
Volume:
3.1M
Avg. volume:
5.6M
1-year change:
24.87%
Market cap:
$121.7B
Revenue:
$24.3B
EPS (TTM):
$1.68
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $15.9B | $15.6B | $16.7B | $19.5B | $24.3B | |
| Revenue Growth (YoY) | 7.85% | -1.99% | 7.15% | 16.35% | 24.86% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $3.8B | $3.5B | $3.8B | $4.5B | $11.5B | |
| Other Inc / (Exp) | $1.1B | $337.3M | -$31.2M | $372.3M | -- | |
| Operating Expenses | $4B | $3.7B | $4B | $4.7B | $11.5B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $2.7B | $3.6B | $5.9B | $7.4B | $8.6B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | $1.5B | $1.9B | $2.2B | |
| Net Income to Company | $3.2B | $4.5B | $5.7B | $7.2B | $8.2B | |
| Minority Interest in Earnings | -$266.2M | -$191.7M | -$177.7M | -$220.3M | -$418.8M | |
| Net Income to Common Excl Extra Items | $2.5B | $3.4B | $4.2B | $5.3B | $6B | |
| Basic EPS (Cont. Ops) | $0.73 | $0.97 | $1.22 | $1.53 | $1.71 | |
| Diluted EPS (Cont. Ops) | $0.72 | $0.95 | $1.19 | $1.50 | $1.68 | |
| Weighted Average Basic Share | $3.4B | $3.5B | $3.5B | $3.5B | $3.5B | |
| Weighted Average Diluted Share | $3.4B | $3.5B | $3.6B | $3.6B | $3.6B | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $8.5B | $9.1B | $12.2B | $16.4B | $19.2B | |
| Revenue (Reported) | $15.9B | $15.6B | $16.7B | $19.5B | $24.3B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $8.5B | $9.1B | $12.2B | $16.4B | $19.2B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $4.6B | $4.3B | $4.6B | $5.5B | $6.5B | |
| Revenue Growth (YoY) | 15.23% | -7.27% | 8.05% | 19.84% | 18.08% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $384.4M | $414.2M | $2.3B | -$1.1B | $3.3B | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $384.4M | $414.2M | $2.3B | -$1.1B | $3.3B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $961.4M | $1.4B | $1.7B | $2B | $2.2B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $230.3M | $334.3M | $426M | $503.4M | $552.9M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -$61M | -$49.2M | -$46.7M | -$63.6M | -$98.3M | |
| Net Income to Common Excl Extra Items | $670.1M | $1B | $1.2B | $1.4B | $1.6B | |
| Basic EPS (Cont. Ops) | $0.19 | $0.30 | $0.34 | $0.40 | $0.44 | |
| Diluted EPS (Cont. Ops) | $0.19 | $0.29 | $0.34 | $0.39 | $0.44 | |
| Weighted Average Basic Share | $3.5B | $3.5B | $3.5B | $3.5B | $3.5B | |
| Weighted Average Diluted Share | $3.5B | $3.5B | $3.5B | $3.6B | $3.6B | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $2.3B | $2.8B | $3.4B | $4.4B | $4.9B | |
| Revenue (Reported) | $4.6B | $4.3B | $4.6B | $5.5B | $6.5B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $2.3B | $2.8B | $3.4B | $4.4B | $4.9B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $16B | $15.6B | $16.7B | $19.5B | $24.3B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $1.5B | $1.7B | $3.7B | $3.4B | $9.7B | |
| Other Inc / (Exp) | -- | -- | -- | -$75.3M | -- | |
| Operating Expenses | $1.5B | $1.7B | $3.7B | $3.4B | $9.7B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $3.5B | $4.7B | $5.9B | $7.4B | $8.6B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $763.6M | $1.1B | $1.5B | $1.9B | $2.2B | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -$266.1M | -$191.4M | -$177.2M | -$220.2M | -$418.7M | |
| Net Income to Common Excl Extra Items | $2.5B | $3.4B | $4.2B | $5.3B | $6B | |
| Basic EPS (Cont. Ops) | $0.73 | $0.97 | $1.21 | $1.53 | $1.71 | |
| Diluted EPS (Cont. Ops) | $0.72 | $0.95 | $1.19 | $1.50 | $1.68 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $9.2B | $10.2B | $12.2B | $16.4B | $19.2B | |
| Revenue (Reported) | $16B | $15.6B | $16.7B | $19.5B | $24.3B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $9.2B | $10.2B | $12.2B | $16.4B | $19.2B | |
| Period Ending | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2026-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $15.6B | $16.7B | $19.5B | $24.3B | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $1.7B | $3.7B | $3.4B | $9.7B | -- | |
| Other Inc / (Exp) | -- | -- | -$75.3M | -- | -- | |
| Operating Expenses | $1.7B | $3.7B | $3.4B | $9.7B | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $4.7B | $5.9B | $7.4B | $8.6B | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.1B | $1.5B | $1.9B | $2.2B | -- | |
| Net Income to Company | $2B | $2.6B | $3.5B | $4B | -- | |
| Minority Interest in Earnings | -$191.4M | -$177.2M | -$220.2M | -$418.7M | -- | |
| Net Income to Common Excl Extra Items | $3.4B | $4.2B | $5.3B | $6B | -- | |
| Basic EPS (Cont. Ops) | $0.97 | $1.21 | $1.53 | $1.71 | -- | |
| Diluted EPS (Cont. Ops) | $0.95 | $1.19 | $1.50 | $1.68 | -- | |
| Weighted Average Basic Share | $13.9B | $13.9B | $14B | $14.1B | -- | |
| Weighted Average Diluted Share | $14.2B | $14.2B | $14.3B | $14.3B | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $10.2B | $12.2B | $16.4B | $19.2B | -- | |
| Revenue (Reported) | $15.6B | $16.7B | $19.5B | $24.3B | -- | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $10.2B | $12.2B | $16.4B | $19.2B | -- | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $24.7B | $28.2B | $19.9B | $22.8B | $25B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $1.5B | $1.4B | $1.8B | $2.5B | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $46.6M | $58.8M | $109.7M | $105.9M | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $30.9B | $37.4B | $30.1B | $33.4B | $25B | |
| Property Plant And Equipment | $1.5B | $1.4B | $1.3B | $1.6B | $1.8B | |
| Long-Term Investments | $73.1B | $54.9B | $60.4B | $79.4B | $103.6B | |
| Goodwill | $14.7M | $13.4M | $12.3M | $296.7M | $989M | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $214.3B | $231.1B | $238.5B | $283.5B | $308.9B | |
| Accounts Payable | $338.1M | $363M | $406.7M | $467.5M | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $7.7B | $6B | $6.2B | $11.7B | -- | |
| Long-Term Debt | $18.5B | $19.7B | $21.2B | $22B | $25.6B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $191.5B | $206.3B | $211.6B | $251.1B | $270.5B | |
| Common Stock | $188.4M | $183.3M | $170.1M | $168.4M | $166.5M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $21.5B | $24B | $26.1B | $30.7B | $36.7B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $1.3B | $788.8M | $814.4M | $1.7B | $1.7B | |
| Total Equity | $22.8B | $24.8B | $26.9B | $32.4B | $38.4B | |
| Total Liabilities and Equity | $214.3B | $231.1B | $238.5B | $283.5B | $308.9B | |
| Cash and Short Terms | $24.7B | $28.2B | $19.9B | $22.8B | $25B | |
| Total Debt | $19.1B | $20.9B | $22.4B | $24.1B | $25.6B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $24.7B | $28.2B | $19.9B | $22.8B | $25B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $1.5B | $1.4B | $1.8B | $2.5B | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $46.6M | $58.8M | $109.7M | $105.9M | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $30.9B | $37.4B | $30.1B | $33.4B | $25B | |
| Property Plant And Equipment | $1.5B | $1.4B | $1.3B | $1.6B | $1.8B | |
| Long-Term Investments | $73.1B | $54.9B | $60.4B | $79.4B | $103.6B | |
| Goodwill | $14.7M | $13.4M | $12.3M | $296.7M | $989M | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $214.3B | $231.1B | $238.5B | $283.5B | $308.9B | |
| Accounts Payable | $338.1M | $363M | $406.7M | $467.5M | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $7.7B | $6B | $6.2B | $11.7B | -- | |
| Long-Term Debt | $18.5B | $19.7B | $21.2B | $22B | $25.6B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $191.5B | $206.3B | $211.6B | $251.1B | $270.5B | |
| Common Stock | $188.4M | $183.3M | $170.1M | $168.4M | $166.5M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $1.3B | $788.8M | $814.4M | $1.7B | $1.7B | |
| Total Equity | $22.8B | $24.8B | $26.9B | $32.4B | $38.4B | |
| Total Liabilities and Equity | $214.3B | $231.1B | $238.5B | $283.5B | $308.9B | |
| Cash and Short Terms | $24.7B | $28.2B | $19.9B | $22.8B | $25B | |
| Total Debt | $19.1B | $20.9B | $22.4B | $24.1B | $25.6B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $3.2B | $4.5B | $5.7B | $7.2B | $8.2B | |
| Depreciation & Amoritzation | $197.8M | $197.3M | $203.9M | $241.1M | $318.2M | |
| Stock-Based Compensation | $1M | $35.8M | $64.6M | $84.9M | $93.5M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $18.6B | $7.8B | -$470.4M | $19B | $14.5B | |
| Capital Expenditures | $227M | $249.7M | $307.8M | $444.4M | $564.2M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$8.5B | -$5.3B | -$8.5B | -$17.6B | -$9.1B | |
| Dividends Paid (Ex Special Dividend) | -- | -$186M | -$434M | -$676.3M | -$832.9M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $4B | $4.8B | $5.2B | $4.7B | $4.8B | |
| Long-Term Debt Repaid | -$7.1B | -$4.6B | -$3.4B | -$4.7B | -$4.7B | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$7.4B | $2.3B | $3.1B | $1.7B | $661.1M | |
| Beginning Cash (CF) | $17.2B | $19.8B | $22.8B | $16.5B | $19.3B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $2.7B | $4.9B | -$5.9B | $3B | $6B | |
| Ending Cash (CF) | $19.8B | $24.6B | $17B | $19.7B | $25.3B | |
| Levered Free Cash Flow | $18.3B | $7.6B | -$778.2M | $18.6B | $14B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | $277.7K | $17.1M | $32.6M | $43M | $48.7M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | $125.9M | $114.5M | $127.9M | $228.3M | $333M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -$186.9M | -$436.1M | -$677.1M | -$840.5M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
| Period Ending | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2026-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $2B | $2.6B | $3.5B | $4B | -- | |
| Depreciation & Amoritzation | $96.2M | $63.3M | $86.8M | $154M | -- | |
| Stock-Based Compensation | $17.1M | $32.6M | $43M | $48.7M | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $7.6B | -$2.6B | $24.5M | $5.4B | -- | |
| Capital Expenditures | $114.5M | $127.9M | $228.3M | $333M | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$3.1B | -$5.2B | -$419.9M | -$5.9B | -- | |
| Dividends Paid (Ex Special Dividend) | -$186.9M | -$436.1M | -$677.1M | -$840.5M | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $1.1B | $1.9B | $1.6B | $2.6B | -- | |
| Long-Term Debt Repaid | -$2.7B | -$1.6B | -$2.4B | -$2.6B | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$2.2B | $2.2B | -$503.1M | $704.3M | -- | |
| Beginning Cash (CF) | $19.8B | $23B | $16.5B | $19.4B | -- | |
| Foreign Exchange Rate Adjustment | -$3.9M | $31.8M | $9M | $6.1M | -- | |
| Additions / Reductions | $2.2B | -$5.6B | -$898.4M | $186.8M | -- | |
| Ending Cash (CF) | $22.1B | $17.4B | $15.6B | $19.6B | -- | |
| Levered Free Cash Flow | $7.4B | -$2.8B | -$203.7M | $5.1B | -- | |
Get IBN Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
IBN
Sector
P/E ratio
20.30x
11.37x
PEG ratio
1.64x
0.38x
P/B ratio
3.32x
1.04x
Price / LTM sales
5.04x
2.45x
Growth Metrics
IBN
Sector
Revenue growth
18.08%
5.74%
Earnings growth
10.68%
6.25%
Revenue (5-year growth)
10.47%
5.15%
Earnings forecast
$0.37
$0.57
Profitability
IBN
Sector
Profitability FY 2025
--
$150.9M
Return on invested capital
9.97%
5.47%
Return on assets
2.04%
0.98%
Return on equity
17.09%
9.38%
Earnings Date
Last Earnings Date
Apr
19
Next Earnings Date
Jul
25
Estimated Next Earnings Date
Jul
19
Balance Sheet
IBN
Sector
Total cash
$25B
$523.5M
Short term investments
--
$237.7M
Total assets
$308.9B
$4.1B
Long term debt
$25.6B
$299.6M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire The Best Stock to Buy in a Bad Market?
Berkshire Hathaway (NYSE:BRK.A, BRK.B) has historically been one of the…
Is Shopify Stock Still a Buy in 2025 or Has Growth Peaked?
The big picture trends in e‑commerce sales are clearly in…
Stock Ideas
Buy
71
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
63
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Alerts
Buy
60
RGC alert for May 6
Regencell Bioscience Holdings [RGC] is up 73.72% over the past day.
Buy
63
SKX alert for May 6
Skechers USA [SKX] is down 0.07% over the past day.
Sell
20
PTCT alert for May 6
PTC Therapeutics [PTCT] is down 11% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
